Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07702292 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 65 to 71
    • Eligibility criteria expanded, about 27 words
    • Secondary endpoints: details revised at 1 of 5 entries
    • Site details revised at 1 of 6 sites
  2. Start date changed from estimate of Jun 2026 to Jun 30, 2026v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Blue Earth Diagnostics
5 trials monitored
See all monitored trials
Breast Cancer
5,418 trials monitored
See 296 trials at risk
Colorectal Cancer
3,394 trials monitored
See 159 trials at risk
Pancreatic Cancer
1,739 trials monitored
See 106 trials at risk
and 2 more diseases
This is a multi-centre, open-label, single-arm, Phase 2 study designed to evaluate the diagnostic performance of \[68Ga\]BED003 in detecting colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
Trial Details
NCT Number NCT07702292
Lead Sponsor Blue Earth Diagnostics
Collaborators: Medpace, Inc.
Conditions
(from sponsor)		 Colorectal Cancer, Epithelial Ovarian Cancer, Gastric Cancer (GC), Pancreatic Ductal Adenocarcinoma (PDAC), Invasive Lobular Breast Carcinoma
Related terms Carcinoma, Lobular, Carcinoma, Ovarian Epithelial, Colorectal Neoplasms, Stomach Neoplasms
Enrollment 71 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov